Primal Kaur

Company: Amgen
Job title: Vice President Global Development
Seminars:
Comparing & Contrasting Clinical Endpoints in Urticaria & Atopic Dermatitis | VIRTUAL 2:00 pm
Outlining the MOA of Tezepelumab-ekko, a monoclonal antibody for chronic spontaneous urticaria Exploring the novel endpoints in development Validating scales for atopic dermatitis clinical endpointsRead more
day: Day 1 PM - Track A